FILANA THERAPEUTICS, INC. 8-K

What Happened

• Filana Therapeutics, Inc. (formerly Cassava Sciences, Inc.) announced a legal name change effective March 10, 2026. The company filed a Certificate of Amendment with the Delaware Secretary of State to effect the change and the board adopted Amended and Restated By‑Laws reflecting the new name, effective the same date.
• The company’s common stock will begin trading on the Nasdaq under the new ticker symbol "FLNA" effective March 11, 2026. The corporate website has changed from www.cassavasciences.com to www.filanatx.com.

Key Details

• Name change effective: March 10, 2026 (Certificate of Amendment filed in Delaware).
• Nasdaq ticker change effective: March 11, 2026 — new symbol FLNA.
• By‑laws updated: Amended and Restated By‑Laws adopted March 10, 2026 to modernize provisions on meetings, notice requirements, director terms, special meetings, inspectors of election, and uncertificated shares.
• No other changes were made to the company’s Restated Certificate of Incorporation besides the name change. Investor materials and SEC filings will be posted on the new website (website content not incorporated by reference).

Why It Matters

• For investors, the practical effects are a new corporate identity and a new Nasdaq ticker (FLNA) starting March 11, 2026 — update any watchlists, trading instructions, or broker records accordingly.
• The filing confirms the company made by‑law clarifications but did not alter the Restated Certificate of Incorporation beyond the name change, so there are no disclosed changes to share rights or structure in this filing.
• The company’s investor relations information, filings and governance documents will be available at the new website (www.filanatx.com), which is where future disclosures and any Code of Conduct amendments will be posted.